- Home
- VTVT vs NMTC Comparison
VTVT vs NMTC Comparison
Compare VTVT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- NMTC
- Stock Information
- Founded
- VTVT 2015
- NMTC 2009
- Country
- VTVT United States
- NMTC United States
- Employees
- VTVT N/A
- NMTC N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- VTVT Health Care
- NMTC Health Care
- Exchange
- VTVT Nasdaq
- NMTC Nasdaq
- Market Cap
- VTVT 45.8M
- NMTC 36.8M
- IPO Year
- VTVT 2015
- NMTC N/A
- Fundamental
- Price
- VTVT $14.98
- NMTC $0.78
- Analyst Decision
- VTVT Strong Buy
- NMTC Strong Buy
- Analyst Count
- VTVT 2
- NMTC 1
- Target Price
- VTVT $35.50
- NMTC $1.45
- AVG Volume (30 Days)
- VTVT 1.4K
- NMTC 308.0K
- Earning Date
- VTVT 08-12-2025
- NMTC 08-14-2025
- Dividend Yield
- VTVT N/A
- NMTC N/A
- EPS Growth
- VTVT N/A
- NMTC N/A
- EPS
- VTVT N/A
- NMTC N/A
- Revenue
- VTVT $17,000.00
- NMTC $6,629,051.00
- Revenue This Year
- VTVT N/A
- NMTC $157.28
- Revenue Next Year
- VTVT N/A
- NMTC $41.79
- P/E Ratio
- VTVT N/A
- NMTC N/A
- Revenue Growth
- VTVT N/A
- NMTC 69.00
- 52 Week Low
- VTVT $12.62
- NMTC $0.40
- 52 Week High
- VTVT $26.99
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- VTVT 49.05
- NMTC 45.91
- Support Level
- VTVT $15.05
- NMTC $0.73
- Resistance Level
- VTVT $15.84
- NMTC $1.01
- Average True Range (ATR)
- VTVT 0.26
- NMTC 0.08
- MACD
- VTVT 0.14
- NMTC -0.01
- Stochastic Oscillator
- VTVT 62.19
- NMTC 13.99
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.